Brief: Bionano Announces Peer-Reviewed Publication From Its Clinical Study Designed To Support OGM As Part Of Standard Of Care In Genetic Disease Testing
11/01/2024 22:44
Jan 11 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO ANNOUNCES PEER-REVIEWED PUBLICATION FROM ITS
CLINICAL
STUDY DESIGNED TO SUPPORT OGM AS PART OF STANDARD OF CARE (SOC)
IN GENETIC DISEASE TESTING
Source text for Eikon: ID:nGNX60Mjr8
Further company coverage: BNGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt